Literature DB >> 8504580

Ethanol-induced myocardial ischemia: close relation between blood acetaldehyde level and myocardial ischemia.

H Ando1, H Abe, R Hisanou.   

Abstract

A patient with vasospastic angina who developed myocardial ischemia following ethanol ingestion but not after exercise was described. Myocardial ischemia was evidenced by electrocardiograms (ECGs) and thallium-201 scintigrams. The blood acetaldehyde level after ethanol ingestion was abnormally high. The time course and severity of myocardial ischemia coincided with those of the blood ethanol and acetaldehyde level. Coronary arteriography showed ergonovine maleate-induced coronary vasospasm at the left anterior descending coronary artery. ECG changes similar to those induced by ethanol ingestion were observed at the same time. These findings suggest that the high blood acetaldehyde level might be responsible for the development of coronary vasospasm and myocardial ischemia in this patient.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504580     DOI: 10.1002/clc.4960160514

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  3 in total

1.  Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues.

Authors:  Tapan Kumar Kundu; Russ Hille; Murugesan Velayutham; Jay L Zweier
Journal:  Arch Biochem Biophys       Date:  2007-01-23       Impact factor: 4.013

2.  Characterization of the magnitude and mechanism of aldehyde oxidase-mediated nitric oxide production from nitrite.

Authors:  Haitao Li; Tapan Kumar Kundu; Jay L Zweier
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

3.  Acute ethanol exposure increases the susceptibility of the donor hearts to ischemia/reperfusion injury after transplantation in rats.

Authors:  Shiliang Li; Sevil Korkmaz; Sivakkanan Loganathan; Alexander Weymann; Tamás Radovits; Enikő Barnucz; Kristóf Hirschberg; Peter Hegedüs; Yan Zhou; Liang Tao; Szabolcs Páli; Gábor Veres; Matthias Karck; Gábor Szabó
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.